AADI (Aadi Bioscience Inc) vs S&P 500 Comparison

AADI

S&P 500

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

AADI

S&P 500

Difference

1Y 3Y 5Y 10Y 15Y 20Y

AADI

S&P 500

Add Stock

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

S&P 500

AADI

ABBV

AMGN

GILD

VRTX

Add Stock

1Y 3Y 5Y 10Y 15Y 20Y

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Aadi Bioscience Inc
Glance View

Market Cap

88.6m USD

Industry

Biotechnology

Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Pacific Palisades, California and currently employs 39 full-time employees. The company went IPO on 2018-06-26. The Company’s primary focus is to bring transformational therapies to cancer patients with mechanistic target of rapamycin (mTOR) pathway driver alterations such as alterations in TSC1 or TSC2 genes. The Company’s initial focus is the treatment of an ultra-rare cancer perivascular epithelioid cell tumor (PEComa). The Company’s lead product, FYARROTM, is an mTOR inhibitor bound to human albumin that has tumor accumulation, mTOR target suppression, and tumor growth inhibition over other mTOR inhibitors in preclinical models. FYARRO is an mTOR inhibitor indicated for the treatment of adult patients with advanced unresectable or metastatic perivascular epithelioid cell tumor (PEComa).

View AADI Analysis

AADI Intrinsic Value

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

	Franklin Covey Co NYSE:FC	35.3 USD
	Mohawk Industries Inc NYSE:MHK	118.28 USD 0.84%
	Ardmore Shipping Corp NYSE:ASC	12.56 USD -1.64%
	ASGN Inc NYSE:ASGN	86.92 USD
	Skyworks Solutions Inc NASDAQ:SWKS	92.63 USD -0.03%
	Weatherford International PLC NASDAQ:WFRD	72.13 USD -3.57%

	Johnson & Johnson NYSE:JNJ	142.27 USD
	Bank of America Corp NYSE:BAC	46.21 USD
	Mastercard Inc NYSE:MA	516.4 USD 0.98%
	Salesforce Inc NYSE:CRM	326.9 USD
	Abbvie Inc NYSE:ABBV	178.5 USD -0.57%
	Home Depot Inc NYSE:HD	387.2 USD

	Arista Networks Inc NYSE:ANET	115.51 USD
	Visa Inc NYSE:V	312.6 USD
	Texas Pacific Land Corp NYSE:TPL	1 275.94 USD 1.4%
	KLA Corp NASDAQ:KLAC	686.2 USD -0.45%
	Manhattan Associates Inc NASDAQ:MANH	272.49 USD 1.6%
	Pinduoduo Inc NASDAQ:PDD	100.32 USD

	Salesforce Inc NYSE:CRM	326.9 USD
	ServiceNow Inc NYSE:NOW	1 049.08 USD -0.48%
	EOG Resources Inc NYSE:EOG	128.46 USD 0.71%
	Copart Inc NASDAQ:CPRT	56.78 USD 0.96%
	Applied Materials Inc NASDAQ:AMAT	176.99 USD -0.47%
	Synopsys Inc NASDAQ:SNPS	502 USD 2.95%

	Johnson & Johnson NYSE:JNJ	142.27 USD
	Berkshire Hathaway Inc NYSE:BRK.A	677 925 USD
	Bank of America Corp NYSE:BAC	46.21 USD
	Mastercard Inc NYSE:MA	516.4 USD 0.98%
	UnitedHealth Group Inc NYSE:UNH	524.52 USD
	Exxon Mobil Corp NYSE:XOM	106.93 USD

AADI

vs

S&P 500

Stocks Performance
AADI vs S&P 500

Performance Gap
AADI vs S&P 500

Performance By Year
AADI vs S&P 500

Competitors Performance
Aadi Bioscience Inc vs Peers

Aadi Bioscience Inc
Glance View

Company

Help

Tools

Stocks

FR		Pharnext SCA OTC:PNEXF	Add
US		Abbvie Inc NYSE:ABBV	Add
US		Amgen Inc NASDAQ:AMGN	Add
US		Gilead Sciences Inc NASDAQ:GILD	Add
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Add
US	E	Epizyme Inc F:EPE	Add
AU		CSL Ltd ASX:CSL	Add
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	Add
US	S	Seagen Inc F:SGT	Add
NL		argenx SE XBRU:ARGX	Add

FR		Pharnext SCA OTC:PNEXF	Select
US		Abbvie Inc NYSE:ABBV	Select
US		Amgen Inc NASDAQ:AMGN	Select
US		Gilead Sciences Inc NASDAQ:GILD	Select
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Select
US	E	Epizyme Inc F:EPE	Select
AU		CSL Ltd ASX:CSL	Select
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	Select
US	S	Seagen Inc F:SGT	Select
NL		argenx SE XBRU:ARGX	Select

US	G	GE Vernova LLC NYSE:GEV	Add
NL	N	Nepi Rockcastle NV JSE:NRP	Add
US		Schlumberger NV NYSE:SLB	Add
US	B	Baker Hughes Co NASDAQ:BKR	Add
ID		Amman Mineral Internasional Tbk PT IDX:AMMN	Add
US	R	Reddit Inc NYSE:RDDT	Add
CH	G	Galderma Group AG SIX:GALD	Add
US		Halliburton Co NYSE:HAL	Add
LU		Tenaris SA MIL:TEN	Add
IN		Jio Financial Services Ltd NSE:JIOFIN	Add

AADI vs S&P 500

Stocks Performance AADI vs S&P 500

Performance Gap AADI vs S&P 500

Performance By Year AADI vs S&P 500

Competitors Performance Aadi Bioscience Inc vs Peers

Aadi Bioscience Inc Glance View

Company

Help

Tools

Stocks

AADI

vs

S&P 500

Stocks Performance
AADI vs S&P 500

Performance Gap
AADI vs S&P 500

Performance By Year
AADI vs S&P 500

Competitors Performance
Aadi Bioscience Inc vs Peers

Aadi Bioscience Inc
Glance View